Alvimopan is a peripherally acting mu-opioid receptor antagonist (PAMORA) used primarily to accelerate gastrointestinal recovery following bowel resection surgery with primary anastomosis. Chemically, it is a derivative of the opioid antagonist naloxone. Alvimopan works by selectively blocking the mu-opioid receptors in the gastrointestinal tract, thereby reducing the inhibitory effects of opioids on gut motility and secretion. This leads to faster restoration of bowel function, decreased postoperative ileus (delayed bowel function), and shorter hospital stays. Alvimopan is typically administered orally in the immediate preoperative period and continued for a limited duration postoperatively. It is contraindicated in patients who have received therapeutic doses of opioids for more than 7 consecutive days prior to surgery or in those with a known or suspected gastrointestinal obstruction or perforation.
Buy high quality Alvimopan from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Alvimopan.

Alvimopan

CAT. No. CP-A127000
CAS. No. 156053-89-3
Mol. F. C25H32N2O4
Mol. Wt. 424.54
Stock Status Custom Synthesis
Rel. Cas No 1007347-23-0 (HCl salt) ; 934161-30-5 (Na salt) ; 170098-38-1 (Dihydrate)
VIEW COA Sample PDF

Product Description


  • Synonyms:NA
  • Chemical Name:((S)-2-Benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanoyl)glycine

Request for Quotation : Alvimopan

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...